SOCS2, suppressor of cytokine signaling 2, 8835
N. diseases: 104; N. variants: 8
Source: ALL
Disease | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.060 | AlteredExpression | phenotype | BEFREE | Moreover, we also revealed that miR-196b/SOCS2 expression correlated with T stage and cervical metastasis. miR-196b was demonstrated to be an independent prognostic factor for overall survival of patients with LSCC. | 29753737 | 2018 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | Low levels of <i>SOCS2</i> correlated strongly with disease recurrence and metastasis in clinical specimens. | 28011622 | 2017 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | However, SOCS2 overexpression significantly inhibited the migration and invasion of HCC cells in vitro and inhibited metastasis in vivo. | 27465557 | 2016 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | In contrast, however, castration-resistant bone metastases exhibit reduced levels of SOCS2 in comparison with localized or hormone naive, untreated metastatic tumors. | 24031028 | 2014 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | In addition, the upregulation of SOCS2 in PCa tissues was correlated with the lower Gleason score (P < 0.001), the absence of metastasis (P < 0.001) and the negative PSA failure (P = 0.009); the downregulation of SOCS6 tended to be found in PCa tissues with the higher Gleason score (P = 0.016), the advanced pathological stage (P = 0.007), the positive metastasis (P = 0.020), and the positive PSA failure (P = 0.032). | 23666742 | 2013 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | Lower mRNA expression of HERPUD1, STK39, DHCR24, and SOCS2 in primary prostate tumors was correlated with a higher incidence of metastases after radical prostatectomy. | 16707422 | 2006 |